Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,401 | 11,782 | 18,076 | 25,822 | 28,819 |
| Receivables | 2,083 | 2,402 | 1,681 | 628 | 2 |
| Other current assets | 0 | 586 | 0 | 0 | 0 |
| TOTAL | $10,913 | $16,619 | $22,423 | $29,276 | $31,018 |
| Non-Current Assets | |||||
| PPE Net | 11,702 | N/A | 13,060 | 13,740 | 10,277 |
| Other Non-Current Assets | 5,326 | 17,803 | 5,632 | 9,304 | 13,662 |
| TOTAL | $17,028 | $17,803 | $18,692 | $23,044 | $23,939 |
| Total Assets | $27,941 | $34,422 | $41,115 | $52,320 | $54,956 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,539 | 2,521 | 5,746 | 4,735 | 7,349 |
| TOTAL | $5,204 | $7,782 | $11,287 | $13,474 | $8,215 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 5,050 | 8,000 | 182 |
| Other Non-Current Liabilities | 6,824 | 7,039 | 7,226 | 10,820 | 11,036 |
| TOTAL | $6,824 | $7,039 | $7,226 | $10,820 | $11,036 |
| Total Liabilities | $12,028 | $14,821 | $18,513 | $24,294 | $19,250 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,799 | 8,799 | 8,360 | 8,360 | 8,360 |
| Common Shares | 9 | 8 | 84 | 84 | 84 |
| Retained earnings | -433,017 | -428,049 | -424,193 | -417,273 | -408,029 |
| TOTAL | $15,913 | $19,601 | $22,602 | $28,026 | $35,706 |
| Total Liabilities And Equity | $27,941 | $34,422 | $41,115 | $52,320 | $54,956 |